2006
DOI: 10.2169/internalmedicine.45.1538
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Lymphocytes in Malignant Pleural Effusion on the Therapeutic Efficacy of Intrapleural OK-432 in Lung Cancer Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Since the efficacy of chemotherapy is not very high, this disease remains a challenging type of cancer. Various complications appear in advanced lung cancer, among which malignant pleural effusion occurs frequently, at about 10% (15). In malignant pleural effusion, pleural fluid generally increases progressively, which induces dyspnea and markedly reduces the QOL of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Since the efficacy of chemotherapy is not very high, this disease remains a challenging type of cancer. Various complications appear in advanced lung cancer, among which malignant pleural effusion occurs frequently, at about 10% (15). In malignant pleural effusion, pleural fluid generally increases progressively, which induces dyspnea and markedly reduces the QOL of patients.…”
Section: Introductionmentioning
confidence: 99%
“…OK‐432 is a biological response modifier (BRM), which is a penicillin G‐inactivated and lyophilized preparation of the low‐virulence strain Su of Streptococcus pyogenes. 1 OK‐432 is an approved adjuvant therapeutic agent for malignancies in Japan 2 . OK‐432 exerts its effect by activating the immune system to secrete antitumour agents; 3 however, little is known about its in vivo immunological mechanism.…”
mentioning
confidence: 99%